Clinical impact of radial artery rupture during percutaneous transluminal angioplasty for radiocephalic arteriovenous fistula dysfunction: A single-center retrospective study Authors: Jun Yin, Jinxi Wei, Li Fu, Wei Wang, Fengping Wang Published: 2026 ABSTRACT AbstractObjectiveTo evaluate the long-term patency outcomes of radiocephalic arteriovenous fistulas treated with percutaneous transluminal angioplasty for radial artery stenosis, with a particular focus on the clinical impact of percutaneous transluminal angioplasty–induced radial artery rupture and its endovascular management.MethodsThis single-center retrospective analysis involved all patients diagnosed with arteriovenous fistula dysfunction and radial artery stenosis who were treated with arterial percutaneous transluminal angioplasty at our department from January 2021 to September 2024. In total, 56 patients were ultimately included in the study.ResultsTechnical success was achieved in all patients. Radial artery rupture occurred in 10 of the 56 patients (17.86%) during percutaneous transluminal angioplasty and was successfully managed using prolonged low-pressure balloon inflation combined with localized external compression, without the need for covered stent implantation or surgical repair. At 1 year, primary patency rates were 40.0% in the rupture group and 39.1% in the normal group (p = 0.53), whereas the corresponding secondary patency rates were 90.0% and 87.0%, respectively (p = 0.35).ConclusionPercutaneous transluminal angioplasty is an effective treatment for radiocephalic arteriovenous fistula dysfunction caused by radial artery stenosis. Although dilation-induced radial artery rupture was relatively common in our cohort, it may be safely managed with prolonged low-pressure balloon inflation and localized compression without routine stent implantation or surgical intervention. Importantly, radial artery rupture did not appear to compromise long-term access-circuit patency. These findings apply to overall access-circuit outcomes rather than lesion-level durability. Controlled arterial rupture during percutaneous transluminal angioplasty appears to be a manageable procedural event that was not associated with worse overall access-circuit outcomes in this cohort.Keywords: Arteriovenous fistula, hemodialysis, percutaneous transluminal angioplasty, radial artery rupture, dialysis access dysfunction Introduction Arteriovenous fistulas (AVFs) remain the preferred vascular access for maintenance hemodialysis because of their superior long-term patency and low infection rates.1,2 Despite these advantages, AVFs are prone to dysfunction, most commonly due to stenotic lesions involving the venous outflow tract and, less frequently, arterial inflow.3,4 Although venous stenosis–related AVF dysfunction has been extensively investigated, arterial inflow pathology remains relatively underrecognized.4–6 Previous studies have demonstrated that arterial lesions contributing to fistula non-maturation or dysfunction can be effectively treated using percutaneous transluminal angioplasty (PTA).7–12 However, most available reports primarily focus on technical success and short-term patency. Data specifically addressing the long-term access outcomes following PTA for arterial stenosis, particularly in the setting of procedure-related arterial rupture, remain limited. Between January 2021 and September 2024, we performed PTA for radial artery stenosis in 60 patients presenting with radiocephalic AVF dysfunction. During the intervention, dilation-induced radial artery rupture (RAR) occurred in a subset of patients, whereas others underwent uneventful arterial angioplasty. By systematically comparing clinical outcomes between patients with and without RAR, this study aimed to evaluate the impact of PTA-induced arterial rupture on subsequent AVF patency and share our experience in managing this complication without routine stent implantation. Methods Participants We conducted a single-center retrospective analysis of all patients who underwent PTA for AVF dysfunction at our department from January 2021 to September 2024. In total, 60 patients were initially diagnosed with radial artery stenosis, and all cases represented first-time PTA interventions for radial artery stenosis. Among these, 3 patients died within 3 months postoperatively due to cerebrovascular diseases and severe infections, and 1 patient was lost to follow-up. Eventually, 56 patients were included in the study. During the procedure, RAR confirmed using angiography occurred in 10 patients; these patients were allocated to the ”RAR” group. The remaining 46 patients, in whom radial artery dilation was uneventful, were allocated to the “normal” group. The institutional review board of Chengdu Second People's Hospital reviewed and approved the study protocol (Approval Number: 2023261). All procedures performed in this study involving human participants were conducted in accordance with the ethical standards of the institutional research committee and the Helsinki Declaration of 1975, as revised in 2024. Due to the retrospective nature of the study, the requirement for written informed consent was waived by the institutional review board. Inclusion criteria Patients fulfilling the following criteria were enrolled: (a) radiocephalic AVF established for at least 8 weeks and considered mature, with documented clinical use for hemodialysis; (b) radial artery stenosis confirmed using angiography or preoperative ultrasonography and considered hemodynamically or functionally significant in the context of AVF dysfunction; (c) treatment of the identified radial artery stenosis with PTA. Definition Hemodynamically significant stenosis was defined as a reduction in luminal diameter of ≥50% compared with the adjacent normal vessel segment on angiography or duplex ultrasonography, accompanied with clinical or functional evidence of AVF dysfunction, including decreased dialysis blood flow, elevated venous pressure during hemodialysis, difficult cannulation, inadequate dialysis adequacy, and thrombosis-related dysfunction. In the present study, all included patients had hemodynamically significant radial artery stenosis requiring PTA, although concomitant venous stenosis was present in some patients. The site of stenotic lesions was classified into four types: (a) Radial artery stenosis. Stenotic lesions involving the inflow radial artery proximal to the arteriovenous anastomosis; (b) Juxta-anastomotic segment. Lesions extending from the anastomosis to the juxta-anastomotic venous segment; (c) Puncture site. Lesions adjacent to the cannulation area; and (d) Outflow vein. Venous stenosis located >5 cm from the arteriovenous anastomosis. Percentage stenosis was estimated by comparing the minimal luminal diameter at the stenotic segment with the diameter of the adjacent normal vessel on angiography. RAR was defined as angiographically evident contrast extravasation extending beyond the expected arterial lumen immediately following balloon angioplasty, regardless of whether the extravasation was free or contained. Isolated arterial dissection without contrast extravasation, vessel wall staining, or residual luminal irregularity was not classified as rupture. Pseudoaneurysm formation detected during follow-up was considered a consequence of rupture rather than a diagnostic criterion for RAR. In all patients allocated to the RAR group, the diagnosis was confirmed using intraoperative angiography and independently reviewed by two experienced vascular access interventionists. Both contained and free contrast extravasation beyond the expected arterial lumen were classified as rupture, provided that angiographic evidence of extraluminal contrast leakage was present. Post-intervention primary patency was defined as uninterrupted patency after intervention until the next access intervention. Post-intervention secondary patency was defined as patency after PTA until the AVF was surgically declotted, revised, or abandoned. The primary outcome of this study was post-intervention access-circuit primary and secondary patency. Lesion-level outcomes, including target lesion primary patency (TLPP) and target-region patency, were not predefined because follow-up data were collected at the access-circuit level in routine clinical practice. Consequently, the lesion responsible for subsequent reinterventions could not always be reliably identified retrospectively, precluding accurate assessment of lesion-level patency outcomes. Intervention procedure All patients were administered brachial plexus anesthesia preoperatively. Once satisfactory anesthesia was achieved, the Seldinger technique was employed for retrograde venous access; a 5–6F vascular sheath (Terumo, Tokyo, Japan) was inserted. A guidewire was then navigated through the anastomosis into the brachial artery, followed by angiographic localization of the AVF pathology. For venous stenosis, balloons ranging from 5–8 mm in size (Gladiator, Boston Scientific, USA) were predominantly used for dilation. The size of the balloon for radial artery stenosis was selected according to the diameter of the adjacent normal vessel. In our practice, 4-mm high-pressure balloons (Gladiator, Boston Scientific, USA) were routinely used for radial artery angioplasty to achieve adequate postprocedural inflow. A 5-mm balloon was used in only one patient with persistent residual stenosis after adequate 4-mm balloon dilation. After dilation, angiography was repeated to confirm the procedural outcome. In cases of RAR, prolonged low-pressure balloon inflation for 1–3 min and external compression were performed, followed by angiography to ascertain the results (Figure 1(g) to (l)). Balloon inflation pressure and inflation duration were not prospectively recorded for each individual lesion; therefore, only routine procedural parameters used in our practice are summarized in Table 1 rather than patient-level comparisons. Intervention procedure. (a to f) Procedural sequence in the normal group; (g to l) procedural sequence in the radial artery rupture group. Table 1.Lesion characteristics, procedural parameters, and complications.RAR groupNormal groupp-valueRadial artery only230.21Accompanied with Juxta-anastomotic segment8250.17 Puncture site080.33 Outflow vein0100.18High-pressure balloon10 (100%)46 (100%)Use of 4-mm balloon10 (100%)45 (97.8%)Use of 5-mm balloon0 (0%)1(2.2%)Routine inflation pressure6–8 atm6–8 atmHigh pressure for resistant lesions16–20 atm (selected cases)16–20 atm (selected cases)Routine inflation duration after full balloon expansion30–60 s30–60 sBalloon-to-artery ratio2.11 (2.11–2.59)2.22 (2.11–2.50)0.60RAR: radial artery rupture. Lesion characteristics, procedural parameters, and complications. RAR: radial artery rupture. Post-intervention follow-up All patients underwent regular ultrasound examinations (VINNO 8, China) at our outpatient department every 3–6 months, and telephone follow-up assessments were performed every 6 months for blood pump flow, venous pressure, and arterial pressure using a questionnaire. Reintervention was performed when recurrent or newly developed hemodynamically significant stenosis (>50% reduction in luminal diameter compared with the adjacent normal vessel) was identified in association with recurrent AVF dysfunction. Clinical indications for reintervention included decreased dialysis blood flow, elevated venous pressure during hemodialysis, difficult cannulation, thrombosis-related dysfunction, and inadequate dialysis adequacy. Statistical analyses Data were expressed as mean ± SD values, medians with interquartile ranges (IQRs), or percentages, as appropriate. Percentage stenosis and age of fistula at intervention were not normally distributed; therefore, they were expressed as medians and IQRs. Normally distributed continuous variables were compared using the unpaired Student's t-test, whereas non-normally distributed variables were compared using the Mann–Whitney U test. Categorical variables were analyzed using the chi-square or Fisher's exact test, as appropriate. Post-intervention primary and secondary patency rates were estimated using the Kaplan–Meier method, and differences between groups were compared using the log-rank test. Kaplan–Meier curves were generated using individual patient time-to-event data. Censoring was indicated by tick marks, and numbers at risk were displayed beneath each curve. A two-sided p-value <0.05 was considered statistically significant. Statistical analyses were performed using RStudio for Windows (R version 4.0.2). The reporting of this study conforms to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. 13 Results Demographic and clinical characteristics of patients This study included a total of 56 patients. Demographic and clinical characteristics are summarized in Table 2. The RAR group comprised 10 patients; the mean patient age was 56.20 ± 14.27 years, and 3 of them were female. Preoperative blood flow was 300.30 ± 52.24 mL/min, which increased to 770.30 ± 165.01 mL/min postoperatively. Additionally, eight patients were hypertensive and six were diabetic. The median age of the fistula at intervention was 9.00 (IQR: 6.25–11.50) months. The normal group included 46 patients with a mean age of 55.98 ± 13.62 years; 21 of the patients were female. Their preoperative blood flow was 266.43 ± 83.82 mL/min, and postoperative blood flow was 753.50 ± 146.55 ml/min. Thirty-six of the patients had hypertension and 28 had diabetes. The median age of the fistula at intervention was 11.00 (IQR: 7.25–16.75) months. Significant differences were noted in the serum calcium level (p < 0.05) between the two groups. No significant differences were observed in the radial artery diameter, stenotic lumen diameter, or percentage stenosis between the two groups. Table 2.Comparison of the demographic characteristics between the RAR and normal groups.DemographicsRAR groupNormal groupp-valueAge (years)56.20 (14.27)55.98 (13.62)0.96Sex0.58 Female3/10 (30.00%)21/46 (45.65%) Male7/10 (70.00%)25/46 (54.35%)BBF (mL/min)300.30 (52.24)266.43 (83.82)0.12ABF (mL/min)770.30 (165.01)753.50 (146.55)0.77HBP>0.99 No2/10 (20.00%)10/46 (21.74%) Yes8/10 (80.00%)36/46 (78.26%)DM>0.99 No4/10 (40.00%)18/46 (39.13%) Yes6/10 (60.00%)28/46 (60.87%)Hb99.60 (11.88)103.26 (11.57)0.39Alb36.90 (3.90)38.43 (3.29)0.27Ca2.21 (0.18)2.06 (0.17)0.035P2.44 (0.47)2.25 (0.45)0.25PTH594.60 (164.80)473.43 (189.23)0.06Radial artery diameter1.91 (0.28)1.97 (0.21)0.75Stenotic lumen diameter1.13 ± 0.181.17 ± 0.140.67Percentage stenosis (%)75 (60–85)70 (60–80)0.22Age of fistula at intervention9.00 (6.25,11.50)11.00 (7.25, 16.75)0.08Categorical variables are expressed as frequencies and percentages. Normally distributed continuous variables are presented as mean ± SD, whereas non-normally distributed variables are expressed as median and interquartile range (IQR) values.RAR: radial artery rupture; BBF: blood flow before intervention; ABF: blood flow after intervention; HBP: hypertension; DM: diabetes mellitus; Hb: hemoglobin; Alb: albumin; Ca: serum calcium; P: serum phosphate; PTH: parathyroid hormone. Comparison of the demographic characteristics between the RAR and normal groups. Categorical variables are expressed as frequencies and percentages. Normally distributed continuous variables are presented as mean ± SD, whereas non-normally distributed variables are expressed as median and interquartile range (IQR) values. RAR: radial artery rupture; BBF: blood flow before intervention; ABF: blood flow after intervention; HBP: hypertension; DM: diabetes mellitus; Hb: hemoglobin; Alb: albumin; Ca: serum calcium; P: serum phosphate; PTH: parathyroid hormone. Stenosis site and complications In our investigation, 5 out of 56 fistulas were identified as isolated radial artery stenosis, whereas the remaining 51 exhibited concurrent venous stenoses (Table 1). Most lesions achieved satisfactory luminal expansion at inflation pressures of 6–8 atmosphere (atm), whereas a minority of resistant lesions required higher pressures (16–20 atm). Balloon inflation was generally maintained for an additional 30–60 s after full balloon expansion. The median balloon-to-artery ratio was comparable between the RAR and normal groups (Table 1). Notably, RAR occurred in 10 of the 56 patients (17.86%) during intervention. These patients were managed effectively with low-pressure balloon inflation (2–4 atm) sustained and combined with localized compression for 1–3 min. Among the 10 patients with RAR, 2 developed small pseudoaneurysms following prolonged low-pressure balloon inflation and localized compression. Both were subjected to close ultrasound surveillance during postoperative week 1, along with individualized adjustment of hemodialysis anticoagulation regimens. Follow-up ultrasonography at 6 months and 1 year demonstrated stable pseudoaneurysm size without evidence of enlargement, rupture, distal ischemia, or need for surgical or endovascular intervention. Subsequently, none of the patients developed severe complications such as compartment syndrome, and there was no need for stent placement after the procedure. None of the patients who underwent the procedure experienced any additional complications, including puncture site hematoma and distal limb ischemia. Post-intervention primary and secondary patency rates In this study, all patients successfully underwent hemodialysis 1–2 days following the intervention. The 1-year primary patency rates were 40% and 39.13% in the RAR and normal groups, respectively (p = 0.53, Figure 2); the corresponding secondary patency rates were 90% and 86.96%, respectively (p = 0.35, Figure 3). No significant differences were observed between the two groups. Kaplan–Meier curve demonstrating no statistically significant differences in the post-intervention primary patency rates between the two groups (p = 0.53). Kaplan–Meier curve demonstrating no statistically significant differences in the post-intervention secondary patency rates between the two groups (p = 0.35). Discussion In this retrospective study, we evaluated the clinical impact of RAR occurring during PTA for radiocephalic AVF dysfunction caused by feeding artery stenosis. Among 56 patients undergoing radial artery PTA, 10 (17.86%) experienced dilation-induced rupture. Importantly, all rupture events were successfully managed using prolonged low-pressure balloon inflation combined with brief localized external compression, without the need for emergent stent placement or access abandonment. No procedure-related major complications were observed, and all fistulas remained suitable for hemodialysis within 1–2 days following intervention. Our findings demonstrated no statistically significant difference in the 1-year access-circuit primary or secondary patency between the two groups. Both groups showed comparable overall access outcomes, suggesting that controlled arterial rupture, when appropriately managed, does not necessarily compromise overall vascular access function. Consequently, although our findings indicate that RAR did not adversely affect overall access-circuit patency, they should not be interpreted as direct evidence that RAR does not influence target lesion durability. Future prospective studies incorporating predefined TLPP or target-region patency are warranted. Previous studies have reported that inflow arterial stenosis accounts for approximately 4%–7% of AVF dysfunction cases.5–7 PTA may be effective for restoring access flow in these lesions, although few studies have specifically evaluated rupture-related outcomes. The rupture incidence observed in our cohort (17.86%) was higher than that reported in most previous studies.8–11 Several factors may explain this finding. First, all cases in our study represented first-time PTA interventions for radial artery stenosis, and previously untreated lesions may be more susceptible to rupture because of severe fibrosis and reduced vascular compliance. Second, the radial artery is a relatively small-caliber vessel, and some resistant lesions required high-pressure dilation (16–20 atm) to achieve satisfactory luminal expansion and residual stenosis reduction. Third, long-term hemodialysis patients frequently exhibit advanced vascular calcification and arterial remodeling related to chronic uremia and dialysis-associated vascular injury, which may further increase arterial fragility during angioplasty. Importantly, although the balloon-to-artery ratio was relatively high in both groups, no significant difference was observed between patients with and without RAR. In our practice, balloon selection was based not only on the reference radial artery diameter but also on the need to restore sufficient inflow for effective hemodialysis. In mature radiocephalic AVFs, smaller balloons frequently failed to achieve adequate luminal expansion or satisfactory postprocedural access flow. Therefore, 4-mm balloons were routinely selected despite the relatively small caliber of the radial artery. The comparable balloon-to-artery ratios between groups suggest that balloon oversizing alone is unlikely to account for the occurrence of RAR in this cohort. A review of angiographic findings demonstrated that most rupture events occurred in the inflow radial artery proximal to the arteriovenous anastomosis rather than directly at the anastomotic site itself. In addition, several rupture events appeared to occur in arterial segments exhibiting angiographic features suggestive of calcification. This was a retrospective study; therefore, angiographic calcification severity and ultrasound-based calcification grading had not been routinely documented at the time of intervention, precluding standardized retrospective assessment. However, no standardized assessment of local arterial calcification was performed; therefore, the contribution of vascular calcification to rupture susceptibility remains speculative and should be interpreted as a hypothesis rather than a conclusion supported by direct evidence. Our experience suggests that prolonged low-pressure balloon tamponade combined with localized external compression is an effective and safe strategy for managing dilation-induced RAR. This approach prevents the need for permanent metallic implantation in small-caliber forearm arteries and preserves future vascular access options. The favorable outcomes observed in our cohort may partly be explained by the unique hemodynamic characteristics of radiocephalic AVFs. Following arterial rupture, the radial artery remains directly connected to a low-resistance venous outflow system, allowing blood to preferentially decompress into the cephalic vein along the pressure gradient. This rapid decompression may facilitate spontaneous sealing of contained arterial ruptures when combined with intraluminal balloon tamponade and brief external compression, thereby reducing the risk of persistent extravasation, hematoma expansion, and pseudoaneurysm formation. In our cohort, only two patients developed small pseudoaneurysms after rupture, and both lesions remained stable without enlargement during long-term ultrasound follow-up, further supporting the safety and durability of conservative endovascular management in this setting. In contrast, rupture of peripheral arteries without arteriovenous outflow typically occurs within a high-resistance arterial system, where sustained intraluminal pressure may promote ongoing bleeding and pseudoaneurysm formation, often necessitating covered stent implantation or surgical repair. Certain study limitations merit consideration. First, this was a single-center retrospective study with a relatively small sample size. Second, although all rupture events were successfully managed without major complications, arterial rupture remains a potentially serious event requiring experienced operators and careful intraprocedural monitoring. Importantly, although the rupture incidence in our cohort was higher than the suggested major complication thresholds proposed by the Society of Interventional Radiology Quality Improvement Guidelines for AVF interventions, most rupture events were angiographically confirmed but clinically contained arterial ruptures that were successfully managed conservatively without clinically significant sequelae or the need for surgical or endovascular bailout procedures. Third, the follow-up duration was limited to 1 year, and longer-term outcome studies remain necessary. In addition, standardized imaging-based assessment of local arterial calcification was unavailable because calcification grading was not routinely documented in this retrospective cohort, limiting our ability to evaluate its potential contribution to rupture risk. In addition, patient-level procedural variables potentially associated with rupture risk, including exact inflation pressure, and inflation duration, were not consistently recorded because of the retrospective study design. Consequently, only routine procedural parameters could be summarized, and formal comparative analyses of these variables were not feasible. Finally, because of the limited number of rupture events, we did not perform formal risk-factor modeling. Larger prospective studies are needed to identify predictors of RAR during PTA. In addition, TLPP and target-region patency could not be evaluated because follow-up data were collected at the access-circuit level and the lesion responsible for subsequent reinterventions could not always be reliably identified retrospectively. Therefore, our conclusions should be interpreted as applicable to overall access-circuit outcomes rather than lesion-level durability. Conclusion PTA is an effective treatment for radiocephalic AVF dysfunction caused by radial artery stenosis. Although dilation-induced RAR was relatively common in our cohort, it could be safely managed with prolonged low-pressure balloon inflation and localized compression without routine stent implantation or surgical intervention. Importantly, RAR did not appear to compromise long-term access-circuit patency. These findings apply to overall access-circuit outcomes rather than lesion-level durability. Controlled arterial rupture during PTA appears to be a manageable procedural event that was not associated with worse overall access-circuit outcomes in this cohort. Acknowledgments We thank the patients who participated in this study. Footnotes ORCID iD: Jun Yin https://orcid.org/0009-0008-2277-3027 Ethics approval and consent to participate: All procedures performed in this study involving human participants were conducted in accordance with the ethical standards of the institutional research committee and the Helsinki Declaration of 1975, as revised in 2024. This study was approved by the research ethics committee of Chengdu Second People's Hospital (protocol number: No. 2023261). Due to the retrospective nature of the study, the requirement for informed consent was waived by the institutional review board. Consent for publication: The requirement for consent for publication was waived by the institutional review board due to the retrospective nature of the study. Author's contributions: Jun Yin contributed to study conception and design, performed the interventional procedures, collected clinical data, conducted statistical analyses, and drafted the manuscript. Jinxi Wei contributed to clinical data collection and follow-up. Li Fu contributed to angiographic image collection and figure preparation. Wei Wang contributed to data analyses and statistical review. Fengping Wang coordinated the study, supervised the project, and critically revised the manuscript. All authors reviewed and approved the final manuscript. Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by Health Commission of Sichuan Province (23LCYJ029). The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Availability of data and material: The datasets generated and/or analyzed during the current study are not publicly available due to the privacy of individual medical records but are available from the corresponding author on reasonable request. References